New York State Common Retirement Fund Revance Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 31,338 shares of RVNC stock, worth $80,538. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,338

Previous 31,338 -0.0%

Holding current value

$80,538

Previous $81,000 101.23%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$2.34 - $4.73 $145 - $293	62 Added 0.2%	31,338 $81,000
Q1 2024 May 07, 2024	SELL	$4.65 - $9.31 $19,827 - $39,697	-4,264 Reduced 12.0%	31,276 $154,000
Q4 2023 Feb 01, 2024	BUY	$5.81 - $11.2 $10,789 - $20,798	1,857 Added 5.51%	35,540 $312,000
Q3 2023 Nov 07, 2023	BUY	$11.47 - $25.07 $2,626 - $5,741	229 Added 0.68%	33,683 $386,000
Q2 2023 Aug 07, 2023	SELL	$24.7 - $37.61 $223,189 - $339,843	-9,036 Reduced 21.27%	33,454 $847,000
Q1 2023 May 02, 2023	SELL	$18.36 - $35.27 $185,766 - $356,861	-10,118 Reduced 19.23%	42,490 $1.37 Million
Q4 2022 Jan 30, 2023	BUY	$18.32 - $30.66 $36,823 - $61,626	2,010 Added 3.97%	52,608 $971,000
Q3 2022 Nov 08, 2022	BUY	$14.33 - $28.47 $1,590 - $3,160	111 Added 0.22%	50,598 $1.37 Million
Q2 2022 Aug 04, 2022	SELL	$11.52 - $20.4 $1,555 - $2,754	-135 Reduced 0.27%	50,487 $698,000
Q1 2022 May 05, 2022	BUY	$12.36 - $20.31 $284 - $467	23 Added 0.05%	50,622 $987,000
Q4 2021 Feb 02, 2022	SELL	$12.46 - $27.87 $1,682 - $3,762	-135 Reduced 0.27%	50,599 $826,000
Q3 2021 Nov 02, 2021	SELL	$25.78 - $33.21 $259,965 - $334,889	-10,084 Reduced 16.58%	50,734 $1.41 Million
Q2 2021 Aug 02, 2021	BUY	$26.8 - $31.84 $99,642 - $118,381	3,718 Added 6.51%	60,818 $1.8 Million
Q4 2020 Feb 08, 2021	BUY	$23.41 - $28.34 $117,050 - $141,700	5,000 Added 9.6%	57,100 $1.62 Million
Q2 2020 Aug 07, 2020	BUY	$12.6 - $26.55 $103,320 - $217,710	8,200 Added 18.68%	52,100 $1.27 Million
Q1 2020 May 06, 2020	BUY	$12.46 - $27.81 $54,824 - $122,364	4,400 Added 11.14%	43,900 $650,000
Q4 2019 Feb 05, 2020	SELL	$11.66 - $20.15 $88,616 - $153,140	-7,600 Reduced 16.14%	39,500 $641,000
Q2 2019 Aug 09, 2019	BUY	$10.67 - $15.49 $166,452 - $241,644	15,600 Added 49.52%	47,100 $611,000
Q4 2018 Feb 08, 2019	SELL	$18.06 - $24.96 $90,300 - $124,800	-5,000 Reduced 13.7%	31,500 $634,000
Q2 2018 Aug 10, 2018	BUY	$27.45 - $33.35 $200,385 - $243,455	7,300 Added 25.0%	36,500 $1 Million
Q1 2018 May 10, 2018	BUY	$29.15 - $37.4 $15,682 - $20,121	538 Added 1.88%	29,200 $899,000
Q4 2017 Feb 13, 2018	BUY	$24.55 - $36.3 $131,637 - $194,640	5,362 Added 23.01%	28,662 $1.03 Million
Q2 2017 Aug 11, 2017	BUY	N/A	23,300	23,300 $615,000

Others Institutions Holding RVNC

# of Institutions

232

Shares Held

82.1M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Revance Therapeutics, Inc. Transaction History